157 related articles for article (PubMed ID: 27832522)
21. Resistance to the atypical retinoid ST1926 in SK-N-AS cells selected the subline rAS-ST with enhanced sensitivity to ATRA mediated by not conventional mechanisms: DNA damage, G2 accumulation and late telomerase inhibition.
Di Francesco AM; Cusano G; Franzese O; Orienti I; Falconi M; Vesci L; Riccardi R
Toxicol In Vitro; 2015 Oct; 29(7):1628-38. PubMed ID: 26096597
[TBL] [Abstract][Full Text] [Related]
22. retSDR1, a short-chain retinol dehydrogenase/reductase, is retinoic acid-inducible and frequently deleted in human neuroblastoma cell lines.
Cerignoli F; Guo X; Cardinali B; Rinaldi C; Casaletto J; Frati L; Screpanti I; Gudas LJ; Gulino A; Thiele CJ; Giannini G
Cancer Res; 2002 Feb; 62(4):1196-204. PubMed ID: 11861404
[TBL] [Abstract][Full Text] [Related]
23. In vivo imaging of retinoic acid receptor beta2 transcriptional activation by the histone deacetylase inhibitor MS-275 in retinoid-resistant prostate cancer cells.
Qian DZ; Ren M; Wei Y; Wang X; van de Geijn F; Rasmussen C; Nakanishi O; Sacchi N; Pili R
Prostate; 2005 Jun; 64(1):20-8. PubMed ID: 15651062
[TBL] [Abstract][Full Text] [Related]
24. Sub-micromolar concentrations of retinoic acid induce morphological and functional neuronal phenotypes in SK-N-SH neuroblastoma cells.
Harasym E; McAndrew N; Gomez G
In Vitro Cell Dev Biol Anim; 2017 Oct; 53(9):798-809. PubMed ID: 28840512
[TBL] [Abstract][Full Text] [Related]
25. Synergistic effects of acyclic retinoid and OSI-461 on growth inhibition and gene expression in human hepatoma cells.
Shimizu M; Suzui M; Deguchi A; Lim JT; Xiao D; Hayes JH; Papadopoulos KP; Weinstein IB
Clin Cancer Res; 2004 Oct; 10(19):6710-21. PubMed ID: 15475462
[TBL] [Abstract][Full Text] [Related]
26. [Effects of tyrosine kinase receptor B and brain-derived neurotrophic factor on chemoresistance in neuroblastoma].
Li AM; Zhang JH; Zhang JH; Zhang KR; Rong DJ
Zhonghua Er Ke Za Zhi; 2006 Jul; 44(7):535-9. PubMed ID: 17044982
[TBL] [Abstract][Full Text] [Related]
27. Retinoic acid induces neuroblastoma cell death by inhibiting proteasomal degradation of retinoic acid receptor alpha.
Nagai J; Yazawa T; Okudela K; Kigasawa H; Kitamura H; Osaka H
Cancer Res; 2004 Nov; 64(21):7910-7. PubMed ID: 15520197
[TBL] [Abstract][Full Text] [Related]
28. Epigenetic Regulation of Cytosolic Phospholipase A2 in SH-SY5Y Human Neuroblastoma Cells.
Tan CS; Ng YK; Ong WY
Mol Neurobiol; 2016 Aug; 53(6):3854-3872. PubMed ID: 26162318
[TBL] [Abstract][Full Text] [Related]
29. Retinoids, retinoic acid receptors, and cancer.
Tang XH; Gudas LJ
Annu Rev Pathol; 2011; 6():345-64. PubMed ID: 21073338
[TBL] [Abstract][Full Text] [Related]
30. Activation of retinoic acid receptor alpha is sufficient for full induction of retinoid responses in SK-BR-3 and T47D human breast cancer cells.
Schneider SM; Offterdinger M; Huber H; Grunt TW
Cancer Res; 2000 Oct; 60(19):5479-87. PubMed ID: 11034091
[TBL] [Abstract][Full Text] [Related]
31. DNA methyltransferase inhibitor RG108 and histone deacetylase inhibitors cooperate to enhance NB4 cell differentiation and E-cadherin re-expression by chromatin remodelling.
Savickiene J; Treigyte G; Jazdauskaite A; Borutinskaite VV; Navakauskiene R
Cell Biol Int; 2012 Nov; 36(11):1067-78. PubMed ID: 22845560
[TBL] [Abstract][Full Text] [Related]
32. Acyclic Retinoid Combined With Tenascin-C-derived Peptide Reduces the Malignant Phenotype of Neuroblastoma Cells Through N-Myc Degradation.
Otsuka K; Sasada M; Hirano YU; Nohara Y; Iyoda T; Higami Y; Kodama H; Fukai F
Anticancer Res; 2019 Jul; 39(7):3487-3492. PubMed ID: 31262872
[TBL] [Abstract][Full Text] [Related]
33. All-trans retinoic acid-responsive genes identified in the human SH-SY5Y neuroblastoma cell line and their regulated expression in the nervous system of early embryos.
Merrill RA; Ahrens JM; Kaiser ME; Federhart KS; Poon VY; Clagett-Dame M
Biol Chem; 2004 Jul; 385(7):605-14. PubMed ID: 15318809
[TBL] [Abstract][Full Text] [Related]
34. Favorable prognostic significance of high-level retinoic acid receptor beta expression in neuroblastoma mediated by effects on cell cycle regulation.
Cheung B; Hocker JE; Smith SA; Norris MD; Haber M; Marshall GM
Oncogene; 1998 Aug; 17(6):751-9. PubMed ID: 9715277
[TBL] [Abstract][Full Text] [Related]
35. Redox balance influences differentiation status of neuroblastoma in the presence of all-trans retinoic acid.
Silvis AM; McCormick ML; Spitz DR; Kiningham KK
Redox Biol; 2016 Apr; 7():88-96. PubMed ID: 26678800
[TBL] [Abstract][Full Text] [Related]
36. Retinoic acid receptors beta and gamma distinguish retinoid signals for growth inhibition and neuritogenesis in human neuroblastoma cells.
Cheung B; Hocker JE; Smith SA; Reichert U; Norris MD; Haber M; Stewart BW; Marshall GM
Biochem Biophys Res Commun; 1996 Dec; 229(1):349-54. PubMed ID: 8954130
[TBL] [Abstract][Full Text] [Related]
37. Enhanced potency of 9-cis versus all-trans-retinoic acid to induce the differentiation of human neuroblastoma cells.
Han G; Chang B; Connor MJ; Sidell N
Differentiation; 1995 Jul; 59(1):61-9. PubMed ID: 7589896
[TBL] [Abstract][Full Text] [Related]
38. The novel atypical retinoid ST1926 is active in ATRA resistant neuroblastoma cells acting by a different mechanism.
Di Francesco AM; Meco D; Torella AR; Barone G; D'Incalci M; Pisano C; Carminati P; Riccardi R
Biochem Pharmacol; 2007 Mar; 73(5):643-55. PubMed ID: 17150196
[TBL] [Abstract][Full Text] [Related]
39. Distinct sensitivity of neuroblastoma cells for retinoid receptor agonists: evidence for functional receptor heterodimers.
Carpentier A; Balitrand N; Rochette-Egly C; Shroot B; Degos L; Chomienne C
Oncogene; 1997 Oct; 15(15):1805-13. PubMed ID: 9362447
[TBL] [Abstract][Full Text] [Related]
40. Expression of co-factors (SMRT and Trip-1) for retinoic acid receptors in human neuroectodermal cell lines.
Bernardini S; Melino G; Saura F; Annicchiarico-Petruzzelli M; Motti C; Cortese C; Federici G
Biochem Biophys Res Commun; 1997 May; 234(1):278-82. PubMed ID: 9169003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
